Cargando…
Where National Medicines Policies Have Taken Us With Patient Involvement and Health Technology Assessment in Africa
The Covid-19 pandemic has highlighted global knowledge about, but lack of equitable access to, life-changing medicines, and other innovative medical products by populations in African low and middle income countries. The World Health Organization (WHO) and other international non-profit foundations...
Autores principales: | Sehmi, Kawaldip, Wale, Janet L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915114/ https://www.ncbi.nlm.nih.gov/pubmed/35281672 http://dx.doi.org/10.3389/fmedt.2022.810456 |
Ejemplares similares
-
Civil society and medical product access in Africa: Lessons from COVID-19
por: Wale, Janet L., et al.
Publicado: (2023) -
Editorial: Where to from here: Advancing patient and public involvement in health technology assessment (HTA) following the COVID-19 pandemic
por: Wale, Janet L., et al.
Publicado: (2023) -
Can We Afford to Exclude Patients Throughout Health Technology Assessment?
por: Wale, Janet L., et al.
Publicado: (2022) -
Patient Involvement in the Health Technology Assessment Process in Taiwan
por: Chen, Kuei An, et al.
Publicado: (2022) -
Digital technologies and healthcare architects' wellbeing in the National Health Service Estate of England during the pandemic
por: Chrysikou, Evangelia, et al.
Publicado: (2023)